arrow
G

Gerwin Huls

University of Groningen
H指数:44
被引数:7,725

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy

急性髓系白血病对维奈克拉和去甲基化药物的耐药机制及提高疗效的策略

2026-01-110
OAAI
Decitabine conditioning improves NK cell maturation and limits CD8+ T cell terminal differentiation post-alloSCT in acute myeloid leukemia patients

地西他滨预处理可改善急性髓系白血病患者的alloSCT后NK细胞成熟并限制CD8+ T细胞终末分化。

2025-11-290
OAAI
Metformin induces ferroptosis associated with lipidomic remodeling in AML

二甲双胍诱导与脂质组重塑相关的铁死亡在AML中

2025-11-040
OAAI
Beneficial effect of PTCy and a short duration of immune suppression on relapse risk in acute myeloid leukemia patients with pretransplant MRD

PTCy和短期免疫抑制对移植前微小残留病(MRD)阳性的急性髓系白血病患者复发风险的有益影响

2025-09-190
PRE
A revised prognostic model for patients with acute myeloid leukemia and first relapse

针对急性髓系白血病首次复发的修订型预后模型

2025-05-260
OA
The Oncogenic ΔNp73α Isoform Contributes to Aggressiveness in APL By Leading to ATRA Resistance through NANOG/BMP4 Axis Upregulation

癌基因ΔNp73α异构体通过上调NANOG/BMP4轴导致ATRA耐药性,从而促进APL的侵袭性。

BLOOD
IF23.1
2024-11-050
PRE
The Oncogenic Function of the Intrinsically Disordered Transcriptional Regulator MN1 Depends on the Chaperone DNAJB6b

内源无序转录调控因子MN1的致癌功能依赖于分子伴侣DNAJB6b

BLOOD
IF23.1
2024-11-050
PRE
Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy
2024-10-102
OAAI
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses

VISTA驱动巨噬细胞朝向促肿瘤表型,促进癌细胞吞噬作用,但下调T细胞反应

2024-03-293
OAAI